ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    HFPEF MANAGEMENT AND IMPLICATION OF EMPEROR-PRESERVED IN CLINICAL PRACTICE: INSIGHTS FROM INDIAN CARDIOLOGISTS


    Dr. Hemant Narayan Ray, Dr. Pradip Mate, Dr. R. V. Lokesh, Dr. Kamlesh Patel
    JCDR. 2023: 2801-2805

    Abstract

    Heart failure with preserved ejection fraction (HFpEF) is a growing burden to the healthcare system due to the lack of proven therapy to reduce mortality and morbidity. Data from the Trivandrum heart failure registry (THFR) reveals that hospital readmissions significantly associated with mortality in patients with HFpEF having a cumulative one-year mortality rate was 27.3%- and three-years mortality was 40.8%.[1] This survey-based study aimed to evaluate the opinion of cardiology experts on the application of EMPEROR-Preserved trial outcomes in clinical practice

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 12

    Keywords